AzurRx BioPharma, Inc.·4

Jul 9, 5:11 PM ET

Pennington James 4

4 · AzurRx BioPharma, Inc. · Filed Jul 9, 2021

Insider Transaction Report

Form 4
Period: 2021-07-09
Pennington James
CHIEF MEDICAL OFFICER
Transactions
  • Award

    Stock option (right to buy)

    2021-07-09+100,000100,000 total
    Exercise: $0.75Exp: 2031-07-09Common stock, par value $0.0001 per share (100,000 underlying)
Footnotes (1)
  • [F1]The stock option vests in 36 equal monthly installments over a term of three (3) years beginning on the date of grant, conditioned on Mr. Pennington's continued employment by AzurRx BioPharma, Inc. on the applicable vesting date.

Documents

1 file
  • 4
    form4-07092021_020744.xmlPrimary